Targeted delivery of functional genes for gene therapy using carbohydrates containing vectors

Voprosy Meditsinskoj Khimii

Volumn 46, Issue 3, 2000, Pages 253-255

  Krivtsov, G G ^a,b   Zhdanov, R I ^b,c  

^a ALL RUSSIA RESEARCH INSTITUTE OF AGRICULTURAL BIOTECHNOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Asialoglycoproteins; Carbohydrate ligands; Chitosans; Glycolipids; Lectins; Neo oligosachharide ligands; Receptor mediated transfer; Targeted gene delivery

Indexed keywords

EID: 0345795269     PISSN: 00428809     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Andersen W.F. et al (1992) Science, 256, 801-813.
2. Xanthopoulos K., ed. (1998) Gene Therapy ASI Series H: Cell Biology, v. 105, Springer, Berlin-Heidelberg-New York.
3. Kaplitt M.G., Loewy D.A. (1995) Viral Vectors: Gene Therapy and Neuroscience Applications, New York, 486 pp.
4. Hodgson C.P, (1996) Retroviral Vectors for Human Gene Therapy, Springer, Berlin-Heidelberg, 149pp.
5. Strauss M., Barrenger J., eds. (1998) Concepts in Gene Therapy, De Gruyter, Berlin.
6. Lasic D.D. (1997) Liposomes in Gene Delivery, Boca Raton, Fl, 295 pp.
7. W.F. Andersen (1998) Therapeutic horizons. Suplement to Nature, 392, 25-30.
8. Lis H. and Sharon N. (1998) Chem. Reviews, 637-674.
9. Gabius H.-J. (1987) Cancer Invest., 5, 39-46.
10. Bovin N. V. (1993) In: Gabius H.-J., ed. Lectins and Glycobiology, Springer, Stuttgart, 23 - 30.
11. Weigel PH. (1994) Bioessays, 16, 519 - 524.
12. Kolb-Bachofen V. (1981) Biochim. Biophys. Acta, 645, 293 - 299.
13. Schwartz A.L. (1984) CRC Crit. Rev. Biochem., 16, 207-233
14. Wu G.Y., Wu C.H., eds (1991) Liver Diseases, Targeted Diagnosis and Therapy Using Specific Receptors and Ligands, Marcel Dekker, Inc, New York.
15. Chowdhury N.R., Wu G.Y., Wu C.H. et al (1993) J. Biol. Chem., 268, 11265-11271.
16. McKee TD., DeRome ME., Wu GY., and Findeis MA. (1994) Bioconjugate Chem., 5, 306-311.
17. Findeis M.A., Merwin J.R., Spitalny G.L. and Chiou H.C. (1993) Trends Biotechnol., 11, 202-205.
18. Chiou H.C., Spitalny G.L., Merwin J.R. and Findeis M.A. (1994) In: Gene Therapeutics: Methods and Applications of Direct Gene Transfer (J.A. Wolff, ed.) Birkhauser, Boston, 143-156.
19. Thurner M., Wagner E., Clausen H. et al (1994) Glycobiology, 4, 429-435.
20. Kwoh D.Y., Coffin C.C., Brostoff S.W., Carlo D.J. (1999) Biochim. Biophys. Acta, 1444, 171 - 190.
21. Merwin J.R., Noell G.S., Thomas W.L. (1994) Bioconjugate Chem., 5, 612-620.
22. Wadhwa M.S., Knoell D.L., Young A.P., Rice K.G. (1995) Bioconjugate Chem., 6,283 - 291.
23. Stahl P.D. (1992) Gurr. Opin. Immunol., 4, 45 - 52.
24. Choi Y.H., Liu F., Park J.S., Kim S. W. (1998) Bioconjug. Chem., 9, 708-718.
25. Erbacher P., Bousser M.-T., Mosigny M., Midoux P., Roche A.C. (1996) XVI Journees Mediteraneennes du Glucides, la Sorgue Groupe Francais des Glucides, AB 22.
26. Erbacher P., Roche A.C., Mosigny M., Midoux P. (1995) Bioconjugate Chem., 6, 401-410.
27. Kren B. T., Bandyopadhyay P, Steer C. (1998) Nature Medicine, 4, 285-290/
28. Diebold S.S., Kursa M., Wagner E., Cotten M., Zenke M. (1999) J. Biol. Chem., 274, 19087-19094.
29. Diebold S. S., Lehrmann H., Kursa M., Wagner E., Cotten M., Zenke M. (1999) Hum. Gene Ther., 10, 775-786.
30. Kollen W.J., Midoux P., Erbacher P. et al (1996) Hum. Gene Ther., 7, 1577-1586.
31. Zhdanov R.I., Serebrennikova G.A., Borisenko A.S., et al (2000) FEBS Lett. (submitted).
32. Stewart A.J, Pichon C., Meunier L. et al (1996) Mol. Pharmacol., 50, 1487-1494.
33. Erbacher P., Zou S., Bettinger T. et al (1998) Pharmaceutical Research., 15,1332-1339.
34. Venkatesh S., Smith J. (1998) Biotechnol. Appl. Biochem., 27, 265-267
35. Venkatesh S., Smith J. (1997) Pharmaceut. Dev. Tech., 2, 417-418.
36. MacLaughlin F.C., Mumper R.J., Wang J. et al (1998) J. Controlled Release, 56,259-272.
37. Lee K.Y., Kwon.I.C., Kim Y.-H. et al (1998) J. Controlled Release, 51, 213-220.
38. Leong K. W., Mao H.-Q., Truong-Le V.L. et al (1998) J. Controlled Release,. 53, 183-193.
39. Mellow T.E., Halberg D., Drickamer K. (1988) J. Biol. Chem., 263, 5468-5473.
40. Bellemin-Magninot P. et al (1992) Int. J. Biochem., 24, 827-830.
41. Yoneda Y., Imamoto-Sonobe N., Yamaizumi M., Uchida T. (1987) Exp. Cell Res., 173, 586-595.
42. Finlay D.R., Newmeyer D.D., Price T.M., and Forbes D.J. (1987) J. Cell Biol., 104, 189-200.
43. Snow D.M., Hart G.W. (1998) Int. Rev. Cytol., 181, 43-47.
44. Duverger E., Carpentier V., Roche AC., Monsigtty M. (1993) Exp. Cell Res., 207, 197-201.
45. Duverger E., Pellerin-Mendes C., Mayer R. et al (1995) J. Cell Sci. 108, 1325 - 1332.
46. Duverger E., Roche A.C., Monsigny M. (1996) Glycobiology, 6, 381 - 386.
47. Richardson SC., Kolbe HV., Duncan R. (1999) Int. J. Pharm., 178, 231-243.
48. Schipper N.G., Olsson S., Hoogstraate J.A. et al (1997) Pharm. Res., 14, 923-929.
49. Borisenko A.S., Krivtsov G.G., Faizulloev E. et al (2000) submitted
50. Akhlynina T.V. et al. (1997) J. Biol. Chem., 272, 20328-20331.
51. Bovin N.V., Gabius H.-J. (1995) Chem. Soc. Rev., 24, 413-421.
52. Bovin N.V. (1996) Rus. J. Bioorg. Chem., 22, 547-566.
53. Gabius S., Kayser K., Bovin N.V. et al (1996) Eur. J. Pharmaceut. Biopharmaceut., 42, 250-261.
54. Zhdanov R.I., Podobed O. V., Bovin N.V. et al (1997) Abstract book of Keystone Symposium "Molecular and Cellular Biology in Gene Therapy", Snowbird, U.S.A., # 107, 10.
55. th Symposium on Gene Therapy "Towards Gene Therapeutics", MDC, Berlin, Germany, May 4-6, 1998, p. 103.